BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16609038)

  • 21. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays.
    Beun GD; Gorter A; Nooyen Y; van de Velde CJ; Fleuren GJ
    J Immunol; 1993 Mar; 150(6):2305-15. PubMed ID: 8450213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies.
    Segal DM; Qian JH; Garrido MA; Perez P; Winkler DF; Wunderlich JR; Snider DP; Valdayo MJ; Titus JA
    Princess Takamatsu Symp; 1988; 19():323-31. PubMed ID: 3269363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model.
    Mezzanzanica D; Garrido MA; Neblock DS; Daddona PE; Andrew SM; Zurawski VR; Segal DM; Wunderlich JR
    Cancer Res; 1991 Oct; 51(20):5716-21. PubMed ID: 1833054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bispecific antibody therapy of two murine B-cell lymphomas.
    Demanet C; Brissinck J; Moser M; Leo O; Thielemans K
    Int J Cancer Suppl; 1992; 7():67-8. PubMed ID: 1428409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bispecific antibody-mediated lysis of placental and germ cell alkaline phosphatase targeted solid tumors in immunocompetent mice.
    Smans KA; Hoylaerts MF; Narisawa S; Millán JL; De Broe ME
    Cancer Res; 1995 Oct; 55(19):4383-90. PubMed ID: 7671251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of gastrin releasing peptide as a lung growth factor].
    Thomas F; Morin A; Moreau JP; Calvo F; Poupon MF
    Rev Mal Respir; 1992; 9(2):125-37. PubMed ID: 1565825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.
    Ferrini S; Cambiaggi A; Sforzini S; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
    Cancer Detect Prev; 1993; 17(2):295-300. PubMed ID: 8402715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer.
    Giffin MJ; Cooke K; Lobenhofer EK; Estrada J; Zhan J; Deegen P; Thomas M; Murawsky CM; Werner J; Liu S; Lee F; Homann O; Friedrich M; Pearson JT; Raum T; Yang Y; Caenepeel S; Stevens J; Beltran PJ; Canon J; Coxon A; Bailis JM; Hughes PE
    Clin Cancer Res; 2021 Mar; 27(5):1526-1537. PubMed ID: 33203642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
    vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
    Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
    Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
    Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.
    Russoniello C; Somasundaram C; Schlom J; Deo YM; Keler T
    Clin Cancer Res; 1998 Sep; 4(9):2237-43. PubMed ID: 9748144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule.
    Scheidegger EP; Lackie PM; Papay J; Roth J
    Lab Invest; 1994 Jan; 70(1):95-106. PubMed ID: 8302024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
    Halmos G; Schally AV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analysis of the 5'-flanking region of the human gastrin-releasing peptide gene in small cell lung carcinoma cell lines.
    Nagalla SR; Spindel ER
    Cancer Res; 1994 Aug; 54(16):4461-7. PubMed ID: 8044796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative study.
    Hardy B; Kovjazin R; Raiter A; Ganor N; Novogrodsky A
    Hum Antibodies; 1997; 8(2):95-8. PubMed ID: 9289394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity of B72.3XOKT3 bispecific antibody recognizing human colon cancer.
    Shpitz B; Stern H; Sandhu JS; Reilley RM; Tropak MB; Jansz G; Xu J; Gallinger S
    J Surg Res; 1996 Feb; 61(1):134-8. PubMed ID: 8769955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
    Moody TW; Venugopal R; Hu V; Gozes Y; McDermed J; Leban JJ
    Peptides; 1996; 17(8):1337-43. PubMed ID: 8971929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data.
    Kuo TH; Kubota T; Watanabe M; Furukawa T; Kase S; Tanino H; Saikawa Y; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1993; 13(3):627-30. PubMed ID: 8391244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma.
    Maruno K; Yamaguchi K; Abe K; Suzuki M; Saijo N; Mishima Y; Yanaihara N; Shimosato Y
    Cancer Res; 1989 Feb; 49(3):629-32. PubMed ID: 2535962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.